Nesiritide (Natrecor®1) is arecombinant form of human B-type (brain) natriuretic peptide that has beneficial vasodilatory, natriuretic, diuretic and neurohormonal effects. The drug is administered intravenously for the management of patients with decompensated congestive heart failure (CHF). In the ...
药物名称：Nesiritide Recombinant 药物别名：脑利钠肽、B-型利钠肽、BNP 英文名称：Natrecor 研发公司：...
毕业论文 > (Nesiritide) Natrecor Recombinant human Brain …:(奈西立肽)脑促尿钠排泄肽重组人脑… 下载文档 收藏 打印 转格式 112阅读文档大小:615.5K20页金雀花上传于2015-05-30格式:PPT null冻干重组人脑利钠肽 热度: 重组人脑利钠肽临床应用进展 ...
STEPS: new drug reviews. Nesiritide (Natrecor) for acute decompensated heart failure American Family PhysicianShatsky M
Nesiritide (Natrecor®) 来自 webarchive.library.unt.edu 喜欢 0 阅读量: 30 作者: NPD Monograph 摘要: of nesiritide is an IV bolus of 2 µg/kg followed by continuous infusion at 0.01 µg/kg/min. There is limited experience in using nesiritide at doses larger than recommended or ...
该药是一种调节肾脏水盐代谢的合成激素,可使血管扩张,商品名为Natrecor,FDA批准严重CHF——代偿失调型(即使休息时也有呼吸急促)可以使用。489名代偿失调型CHF患者被随机分为三组,分别静脉给予Natrecor、硝酸甘油(常用于治疗CHF的扩血管药)和安慰剂。另外,所有病人还接受常规标准疗法。结果,nesiritide组患者病情与硝酸...
内容提示: 【药品名】 奈西立肽 【英文名】 Nesiritide 【别名】 利钠肽; 脑促尿钠排泄肽; Natrecor 【剂型】 注射剂: 1. 5mg(含奈西立肽 1. 58mg, 枸橼酸 2. 1mg, 枸橼酸钠二水合物 294mg) 。 【药理作用】 本品为人工合成的基因重组人 B 型利钠肽(recombined human B-type natriuretic peptide...
Of importance Kesselheim AS, Fischer MA, Avorn J:The rise and fall of Natrecor for congestive heart failure: implications for drug policy.Health Aff (Millwood) 2006,25:1095–1102. The regulatory and marketing history of nesiritide is presented with citation of pertinent landmarks. Article Goog...
6.7Nesiritide (i.e., Natrecor®) Nesiritide, a 32-AA peptide, is a recombinant version of human B-type natriuretic peptide (Elkayam et al., 2002). It is used for patients with decompressed heart failure, in which the heart loses its ability to provide adequate amounts of blood and oxy...
观察奈西立肽静脉给药后健康受试者的耐受性和安全性,并根据临床药代动力学研究,制定本品的Ⅱ期临床试验给药方案,提供安全的推荐剂量。 开始日期- 申办/合作机构- 100项与 奈西立肽(成都圣诺生物制药) 相关的临床结果 登录后查看更多信息 100项与 奈西立肽(成都圣诺生物制药) 相关的转化医学 ...